Search research articles
Contact Us
Filters
Showing results (131-140 of 143) with videos related to
Page
of 15
Sort By:
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
Plos Computational Biology
|
May 10, 2011
Minimum Information About a Simulation Experiment (MIASE)
Dagmar Waltemath, Richard Adams, Daniel A Beard, et al.
Nature Communications
|
August 8, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database
Qian Shi, Aimery de Gramont, Axel Grothey, et al.
BMC Cancer
|
April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
Francesca Aroldi, Elena Elez, Thierry André, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database
Lindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
Therapeutic Advances in Medical Oncology
|
July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
Jun Yin, Shaheenah Dawood, Romain Cohen, et al.
Epigenetics
|
September 28, 2013
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns
Ivana Türbachova, Tim Schwachula, Ines Vasconcelos, et al.
JNCI Cancer Spectrum
|
May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials
Nadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2024
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 143) with videos related to
Sort By:
Page
of 15
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
Plos Computational Biology
|
May 10, 2011
Minimum Information About a Simulation Experiment (MIASE)
Dagmar Waltemath, Richard Adams, Daniel A Beard, et al.
Nature Communications
|
August 8, 2022
Unified classification and risk-stratification in Acute Myeloid Leukemia
Yanis Tazi, Juan E Arango-Ossa, Yangyu Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 12, 2014
Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: findings from the analysis and research in cancers of the digestive system database
Qian Shi, Aimery de Gramont, Axel Grothey, et al.
BMC Cancer
|
April 11, 2025
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)
Francesca Aroldi, Elena Elez, Thierry André, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2017
Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database
Lindsay A Renfro, Richard M Goldberg, Axel Grothey, et al.
Therapeutic Advances in Medical Oncology
|
July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis
Jun Yin, Shaheenah Dawood, Romain Cohen, et al.
Epigenetics
|
September 28, 2013
The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns
Ivana Türbachova, Tim Schwachula, Ines Vasconcelos, et al.
JNCI Cancer Spectrum
|
May 23, 2022
Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials
Nadine J McCleary, William S Harmsen, Ellana Haakenstad, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2024
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis
Romain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.
Page
of 15